Junkai Liu

Controllable thioester-based hydrogen sulfide slow-releasing donors as cardioprotective agents.

Shanshan Luo, Shengtao Xu, Jinyi Xu, 2019, Chemical communications.

Design and synthesis of novel SCM-198 analogs as cardioprotective agents: Structure-activity relationship studies and biological evaluations.

Shanshan Luo, Shengtao Xu, Y. Zhu, 2020, European journal of medicinal chemistry.

Organocatalytic 1,5-trifluoromethylthio-sulfonylation of vinylcyclopropane mediated by visible light in the water phase

Hequan Yao, Jinyi Xu, Hong Yao, 2020 .

Identification of a Potent Oridonin Analog for Treatment of Triple-Negative Breast Cancer.

Zhe-Sheng Chen, Dong-Hua Yang, Shengtao Xu, 2020, Journal of medicinal chemistry.

Identification of new potent anticancer derivatives through simplifying the core structure and modification on their 14- hydroxyl group from oridonin.

Zhe-Sheng Chen, Dong-Hua Yang, Shengtao Xu, 2022, European journal of medicinal chemistry.

The structural modification of natural products for novel drug discovery

Shengtao Xu, Jinyi Xu, Hong Yao, 2017, Expert opinion on drug discovery.

Hit-to-Lead Optimization of the Natural Product Oridonin as Novel NLRP3 Inflammasome Inhibitors with Potent Anti-Inflammation Activity.

Shengtao Xu, Jinyi Xu, Hong Yao, 2024, Journal of medicinal chemistry.